Literature DB >> 1305018

Serotonin (5-HT) and the rat's eye. Some pilot studies.

R M Boerrigter1, J V Siertsema, I P Kema.   

Abstract

Serotonin (5-hydroxytryptamine, 5-HT) is a biogenic amine which has a multitude of more or less clearly established effects on peripheral vessels. It influences blood viscosity, platelet aggregation, and vasoconstruction and -dilatation, it enhances capillary permeability, it is the precursor of melatonin (a hormone with diurnal production in the eye). Because of these actions a role for serotonin in the development of glaucoma and diabetic retinopathy might be suspected. In a series of pilot studies on rats the effects of serotonin on the anterior and posterior segments of the eye were studied. Serotonin had marked influence on the retinal and choroidal vasculature. The optic disk seemed to be very sensitive to serotonin. Possibly it had an influence on the blood-retinal barrier. It caused transient cataracts, probably by decreasing the production of aqueous. It blocked tropicamin-induced mydriasis. The techniques and provisional results of measurement of serotonin in human aqueous are also described.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1305018     DOI: 10.1007/bf00157004

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  28 in total

1.  A circadian rhythm of aqueous flow underlies the circadian rhythm of IOP in NZW rabbits.

Authors:  S D Smith; D S Gregory
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-04       Impact factor: 4.799

2.  Ophthalmic manifestations of the carcinoid flush.

Authors:  V G Wong; K L Melmon
Journal:  N Engl J Med       Date:  1967-08-24       Impact factor: 91.245

3.  [Reversible lens opacities in rats and mice following combined application of phenelzine and serotonin].

Authors:  S Tilgner; T Kusch
Journal:  Ophthalmologica       Date:  1969       Impact factor: 3.250

4.  Vascular reactivities of isolated and perfused human ciliary arteries.

Authors:  H Ohkubo; S Chiba
Journal:  Jpn J Ophthalmol       Date:  1988       Impact factor: 2.447

Review 5.  Prejunctional effects of 5-hydroxytryptamine on noradrenergic nerves in the cardiovascular system.

Authors:  P P Humphrey; W Feniuk; A D Watts
Journal:  Fed Proc       Date:  1983-02

6.  AGGREGATION OF BLOOD CELLS BY 5-HYDROXYTRYPTAMINE (SEROTONIN).

Authors:  R L SWANK; J H FELLMAN; W W HISSEN
Journal:  Circ Res       Date:  1963-11       Impact factor: 17.367

Review 7.  Serotonergic antagonists and vascular disease.

Authors:  P M Vanhoutte
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

8.  Brain transmitter precursors and metabolites in diabetic ketoacidosis.

Authors:  G Curzon; B D Kantamaneni; N Callaghan; P A Sullivan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-06       Impact factor: 10.154

9.  THE EFFECT OF 5-HYDROXYTRYPTAMINE (SEROTONIN) ON RETINAL VESSELS OF THE RAT.

Authors:  T TAMMISTO
Journal:  Acta Ophthalmol (Copenh)       Date:  1965

Review 10.  [Mechanism of action of beta-blockers].

Authors:  X Martin
Journal:  Ophtalmologie       Date:  1990 Mar-Apr
View more
  10 in total

1.  Serotonergic retinopetal axons in the monkey retina.

Authors:  Matthew J Gastinger; Andrea S Bordt; Maria P Bernal; David W Marshak
Journal:  Curr Eye Res       Date:  2005-12       Impact factor: 2.424

Review 2.  Retinopetal axons in mammals: emphasis on histamine and serotonin.

Authors:  Matthew J Gastinger; Ning Tian; Tamas Horvath; David W Marshak
Journal:  Curr Eye Res       Date:  2006 Jul-Aug       Impact factor: 2.424

3.  Selective serotonin reuptake inhibitor use and increased risk of cataract surgery: a population-based, case-control study.

Authors:  Jay C Erie; Scott M Brue; Alanna M Chamberlain; David O Hodge
Journal:  Am J Ophthalmol       Date:  2014-03-14       Impact factor: 5.258

4.  Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure.

Authors:  Ciro Costagliola; Francesco Parmeggiani; Francesco Semeraro; Adolfo Sebastiani
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

5.  Protective effects of Morus alba leaves extract on ocular functions of pups from diabetic and hypercholesterolemic mother rats.

Authors:  H I H El-Sayyad; M A El-Sherbiny; M A Sobh; A M Abou-El-Naga; M A N Ibrahim; S A Mousa
Journal:  Int J Biol Sci       Date:  2011-06-04       Impact factor: 6.580

6.  Anti-platelet effects of anti-glaucomatous eye drops: an in vitro study on human platelets.

Authors:  Marilita M Moschos; Giannis A Moustafa; Vasiliki D Papakonstantinou; Michael Tsatsos; Konstantinos Laios; Smaragdi Antonopoulou
Journal:  Drug Des Devel Ther       Date:  2017-04-19       Impact factor: 4.162

Review 7.  Antidepressants use and risk of cataract development: a systematic review and meta-analysis.

Authors:  Yana Fu; Qi Dai; Liwei Zhu; Shuangqing Wu
Journal:  BMC Ophthalmol       Date:  2018-02-06       Impact factor: 2.209

8.  Circulating neurohormone imbalances in canine sudden acquired retinal degeneration syndrome and canine pituitary-dependent hypercortisolism.

Authors:  Annie Oh; Melanie L Foster; Katharine F Lunn; Freya M Mowat
Journal:  J Vet Intern Med       Date:  2019-10-29       Impact factor: 3.333

9.  Ocular growth and metabolomics are dependent upon the spectral content of ambient white light.

Authors:  Raymond P Najjar; Juan Manuel Chao De La Barca; Veluchamy A Barathi; Candice Ee Hua Ho; Jing Zhan Lock; Arumugam R Muralidharan; Royston K Y Tan; Chetna Dhand; Rajamani Lakshminarayanan; Pascal Reynier; Dan Milea
Journal:  Sci Rep       Date:  2021-04-07       Impact factor: 4.379

10.  Drugs associated with cataract formation represent an unmet need in cataract research.

Authors:  Jack Carlson; Kate McBride; Michael O'Connor
Journal:  Front Med (Lausanne)       Date:  2022-08-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.